Fortress Biotech, Inc. cotiza a 2.11 USD y tiene una capitalización bursátil de $70M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Fortress Biotech, Inc., together with its subsidiaries, operates as a biopharmaceutical company in the United States and internationally. The company offers Emrosi, a minocycline hydrochloride extended-release capsule for the treatment of rosacea; Qbrexza a medicated cloth towelette for the treatment of axillary hyperh…
| Periodo | 2026-05 | 2026-03 | 2025-11 | 2025-08 |
|---|---|---|---|---|
| Real | $2.82 | $-0.21 | $0.11 | $-0.51 |
| Estimado | $-0.22 | $0.11 | $-0.62 | $-0.31 |
| Sorpresa | +1381.8% | -290.9% | +117.7% | -64.5% |
| Métrica | FBIO | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 66.9% | 57.0% | +9.9% |
| Operating Margin | -111.0% | -38.6% | -72.4% |
| Net Margin | 10.8% | -33.6% | +44.3% |
| FCF Margin | — | -13.9% | — |
| ROE | 13.7% | -40.4% | +54.1% |
| ROA | 3.7% | -32.0% | +35.7% |
| Current Ratio | 2.49 | 2.84 | -0.35 |
| Debt / Equity | 1.05 | 0.28 | +0.77 |